CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 59 filers reported holding CARDIFF ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $997,452 | -10.8% | 717,591 | -5.6% | 0.00% | – |
Q2 2023 | $1,117,600 | -10.6% | 760,272 | +0.3% | 0.00% | – |
Q1 2023 | $1,250,400 | +19.1% | 757,818 | +1.1% | 0.00% | – |
Q4 2022 | $1,049,784 | -9.0% | 749,846 | +0.1% | 0.00% | – |
Q3 2022 | $1,153,000 | -22.0% | 749,098 | +11.5% | 0.00% | – |
Q2 2022 | $1,478,000 | -76.1% | 671,967 | -73.1% | 0.00% | – |
Q1 2022 | $6,190,000 | -59.3% | 2,496,120 | -1.4% | 0.00% | – |
Q4 2021 | $15,218,000 | -4.3% | 2,532,248 | +6.1% | 0.00% | – |
Q3 2021 | $15,903,000 | +1.3% | 2,387,748 | +1.2% | 0.00% | – |
Q2 2021 | $15,694,000 | +215.8% | 2,359,983 | +339.7% | 0.00% | – |
Q1 2021 | $4,970,000 | -39.6% | 536,758 | +17.4% | 0.00% | – |
Q4 2020 | $8,224,000 | +66.8% | 457,201 | +31.6% | 0.00% | – |
Q3 2020 | $4,931,000 | +17510.7% | 347,474 | +6163.0% | 0.00% | – |
Q2 2020 | $28,000 | – | 5,548 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 2,522,083 | $15,158,000 | 12.39% |
Octagon Capital Advisors LP | 982,753 | $5,906,000 | 1.15% |
Altium Capital Management LP | 337,000 | $2,025,000 | 0.56% |
ACT CAPITAL MANAGEMENT, LLC | 102,500 | $616,000 | 0.44% |
Eventide Asset Management | 1,670,399 | $10,039,000 | 0.13% |
Artal Group S.A. | 750,000 | $4,508,000 | 0.12% |
Aquatic Capital Management LLC | 8,000 | $48,000 | 0.09% |
ELKHORN PARTNERS LIMITED PARTNERSHIP | 17,300 | $104,000 | 0.06% |
Anson Funds Management LP | 69,381 | $417,000 | 0.04% |
KENNEDY CAPITAL MANAGEMENT LLC | 170,447 | $1,024,000 | 0.02% |